Results 81 to 90 of about 6,064,178 (194)

Human biomarker navigator

open access: yesiMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta   +2 more
wiley   +1 more source

Diagnosis of Chromophobe Renal Cell Carcinoma by Chromosomal Analysis

open access: yes, 1997
Chromophobe renal cell carcinoma may pose a differential diagnostic problem by routine histologic examination because it may be misdiagnosed as another type of renal cancer with a totally different clinical behavior.
Gavino Faa   +4 more
core   +1 more source

Multifocal Synchronous Chromophobe, Papillary, and Clear Cell Renal Cell Carcinoma in a Single Kidney [PDF]

open access: yes, 2018
We present a unique case of concurrent chromophobe, clear cell, and papillary renal cell carcinomas (RCC) in three separate sites in the same kidney after partial nephrectomy. We review the literature of synchronous RCC of up to two histologic subtypes,
Siba El Hussein   +6 more
core   +1 more source

The WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.

open access: yes, 2022
The 5th edition of the WHO Classification of Tumours of the Urinary and Male Genital Systems contains relevant revisions and introduces a group of molecularly defined renal tumour subtypes.
Ohashi, Riuko   +42 more
core   +1 more source

Surgical excision of renal cell carcinoma with caval and intra-atrial tumour thrombus extension using deep hypothermic circulatory arrest [PDF]

open access: yes, 2013
Surgery for tumour thrombus extension in Renal Cell Carcinoma may be associated with a good prognosis if no distant metastases are identified and if the thrombus can be completely excised.
Bugeja, Simon   +3 more
core  

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

open access: yesCell Reports, 2018
Summary: Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses.
Christopher J. Ricketts   +769 more
doaj   +1 more source

Compare fuhrman nuclear and chromophobe tumor grade on chromophobe RCC

open access: yesOpen Medicine, 2019
Chromophobe renal cell carcinoma (chRCC) has a favorable prognosis. Due to irregular nuclei and nuclear pleomorphism, chRCC has a high Fuhrman nuclear grade (FNG).
Lin Tsu-Feng   +6 more
doaj   +1 more source

Pembrolizumab plus lenvatinib enabling cytoreductive nephrectomy in metastatic chromophobe renal cell carcinoma: a case report

open access: yesDrugs in Context
We report the case of a 65-year-old woman diagnosed with metastatic chromophobe renal cell carcinoma, classified as intermediate risk according to IMDC criteria, who presented with a large left renal mass, para-aortic lymphadenopathy and bilateral ...
Laura Palumbo   +4 more
doaj   +1 more source

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery [PDF]

open access: yes, 2014
Background:Wider clinical applications of 9p status in clear cell renal cell carcinoma (ccRCC) are limited owing to the lack of validation and consensus for interphase fluorescent in situ hybridisation (I-FISH) scoring technique.
Fleming, S.   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy